HCAT (Health Catalyst) Ending Cash Position: $0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HCAT Health Catalyst Inc HCAT
49 GF Score
Price $2.33
GF Value $4.99
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Health Catalyst Ending Cash Position?

Health Catalyst HCAT +1.75% 49 Ending Cash Position is $0.0 Mil as of Mar. 2026. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $4.99 (Possible Value Trap). The stock has 5 warning signs investors should review.

Health Catalyst's Ending Cash Position for the quarter that ended in Mar. 2026 was $0.0 Mil.

Health Catalyst's annual Ending Cash Position increased from Dec. 2023 ($106.3 Mil) to Dec. 2024 ($249.6 Mil) but then declined from Dec. 2024 ($249.6 Mil) to Dec. 2025 ($50.8 Mil).

Health Catalyst Ending Cash Position Related Terms

Health Catalyst Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Health Catalyst's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Catalyst Ending Cash Position Chart

Health Catalyst Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 193.23 116.31 106.28 249.65 50.81

Health Catalyst Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HCAT
49GF Score
Health Catalyst Inc HCAT
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health Catalyst Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Health Catalyst's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=249.645+-198.831
=50.8

Health Catalyst's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=-9.05+9.05
=0.0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.0 Mil mean?
Health Catalyst (HCAT) has a Ending Cash Position of $0.0 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Health Catalyst and its competitors.
Is Health Catalyst's Ending Cash Position too high?
Health Catalyst's current Ending Cash Position is $0.0 Mil. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's Ending Cash Position compare to SY and AMWL?
Health Catalyst's Ending Cash Position of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Health Catalyst and its competitors. Health Catalyst's current Ending Cash Position is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $4.99, compared to a current price of $2.33 — trading 53.3% below its estimated fair value. The current Ending Cash Position is $0.0 Mil. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Health Catalyst (HCAT), the current Ending Cash Position is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health Catalyst (HCAT) Overvalued in 2026?

Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued. The current stock price of $2.33 is trading 53.3% below its estimated GF Value™ of $4.99. GuruFocus considers Health Catalyst to be Possible Value Trap.

Key valuation signals for HCAT:

  • Ending Cash Position: $0.0 Mil
  • GF Value™: $4.99 vs. price of $2.33 (53.3% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Health Catalyst Business Description

Other Exchanges 2YP:Germany
Address 10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score

Get the complete analysis for HCAT

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.33
Price
$4.99
GF Value